It has been reported that the expression and activity of the major tau phosphatase in human brain, protein phosphatase-2A (PP2A), is decreased in the affected areas of AD brain [3,4], suggesting that a downregulation of tau phosphatases in AD brain might underlie the abnormal hyperphosphorylation of tau. Here, MAPT is linked to Alzheimer disease.